Day: March 8, 2024

NRSInsights’ February 2024 Retail Same-Store Sales Report

Written by Customer Service on March 8, 2024. Posted in Public Companies.

National Retail SolutionsRetail Trade Comparative DataFebruary same-store sales per calendar day increased 3.5% year-over-year and 7.4% sequentially Retailers in certain Western states recorded the largest year-over-year gains as winter storms triggered stockpiling Average prices increased 1.2% year-over-year NEWARK, N.J., March 08, 2024 (GLOBE NEWSWIRE) — NRSInsights, a provider of sales data and analytics drawn from retail transactions processed through the National Retail Solutions (NRS) point-of-sale (POS) platform, today announced comparative same-store sales results for February 2024. As of February 29, 2024, the NRS retail network comprised approximately 29,100 active terminals scanning purchases at independent retailers including bodegas, convenience stores, liquor stores, grocers, tobacco, and sundries sellers...

BW Offshore: New Long-Term Incentive Programme 2024

Written by Customer Service on March 8, 2024. Posted in Public Companies.

New Long-Term Incentive Programme 2024 The Board of Directors of BW Offshore Limited (“BWO” or the “Company”) has approved a New Long-Term Incentive Programme (LTIP). The programme is a combination of Share Options and Restricted Share Unit (RSUs), aimed to align the interests of the participating employees with those of the Company’s shareholders. The programme is discretionary, and participants are invited on an annual basis. The total number of options awarded under the LTIP for 2024 is 800,000 where each option will give the holder the right to acquire one BW Offshore share. A total of 6 BW Offshore employees have been invited to participate in the Share Option Programme. The strike price of the options is calculated based on the volume weighted average share price five trading days prior to grant date,...

Data Storage Corporation Appoints Nancy M. Stallone and Uwayne A. Mitchell to its Board of Directors

Written by Customer Service on March 8, 2024. Posted in Public Companies.

MELVILLE, N.Y., March 08, 2024 (GLOBE NEWSWIRE) — Data Storage Corporation (Nasdaq: DTST) (“DSC” and the “Company”), a provider of diverse business continuity solutions for disaster-recovery, cloud infrastructure, cyber-security, and IT services, today announced that it has appointed Nancy M. Stallone, CPA, and Uwayne A. Mitchell, Esq., to the Company’s Board of Directors. Ms. Stallone will also serve as a member of the Audit Committee. “Nancy and Uwayne bring extensive experience within their respective fields, and we are delighted to welcome them to our board of directors,” commented Chuck Piluso, Chief Executive Officer of Data Storage Corporation. “Nancy has an impressive background in corporate finance, auditing and accounting, which we believe will be invaluable as we execute on our strategic growth initiatives, including...

Coda Octopus Group, Inc., Sets Fiscal First Quarter 2024 Earnings Conference Call for Monday, March 18, 2024, at 10 a.m. Eastern Time

Written by Customer Service on March 8, 2024. Posted in Public Companies.

Orlando, FL, March 08, 2024 (GLOBE NEWSWIRE) — Coda Octopus Group, Inc. (“CODA” or the “Company”) (NASDAQ: CODA), a global market leader in real-time 3D/4D/5D and 6D imaging sonar technology for real-time subsea intelligence and diving technology, will host a conference call on Monday, March 18, 2024 at 10:00 a.m. Eastern time to discuss its results for its fiscal first quarter ended January 31, 2024 (“FQ2024”). A press release detailing these results will be issued before the open of trading on the same day. CODA management will provide prepared remarks, followed by a question-and-answer period. Date: Monday, March 18, 2024Time: 10:00 a.m. Eastern time (7:00 a.m. Pacific time)U.S. dial-in number: 1-877-451-6152International number: 1-201-389-0879Conference ID: 13744838 The conference call will broadcast live and be available for...

Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights

Written by Customer Service on March 8, 2024. Posted in Earnings Releases And Operating Results.

Topline GSBR-1290 Phase 2a 12-week obesity data, as well as data from formulation bridging and titration optimization study, on track for latter half of the second quarter 2024 Phase 2b study in obesity expected to begin as planned in the fourth quarter 2024 Year-end cash balance of $467.3 million expected to fund operations and key clinical milestones through 2026 SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) — Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases, today reported financial results for the fourth quarter and full year ended December 31, 2023, and highlighted recent corporate achievements. “In 2023 we demonstrated clear proof-of-concept with our lead GLP-1 receptor agonist, GSBR-1290,...

CVR Partners Provides Update on Availability of 2023 K-1 Tax Packages

Written by Customer Service on March 8, 2024. Posted in Public Companies.

SUGAR LAND, Texas, March 08, 2024 (GLOBE NEWSWIRE) — CVR Partners, LP (NYSE: UAN), a manufacturer of ammonia and urea ammonium nitrate (“UAN”) solution fertilizer products, today announced that it continues to monitor Congress and the Biden Administration’s consideration of the proposed H.R. 7024 legislation that, as currently written, would lower CVR Partners’ taxable income for 2023, compared to existing tax law. As previously mentioned in our February 20, 2024, press release, the timing of the availability of the 2023 K-1 tax packages could be impacted by the continued consideration of the proposed H.R. 7024 legislation. At this time, CVR Partners currently expects that 2023 K-1 tax packages will be available on or around March 30, 2024. About CVR Partners, LPHeadquartered in Sugar Land, Texas, CVR Partners, LP is a Delaware...

Safe and Green Development Corp Secures Financing for Norman Berry Expansion in Atlanta, Georgia

Written by Customer Service on March 8, 2024. Posted in Public Companies.

MIAMI, Fla, March 08, 2024 (GLOBE NEWSWIRE) — Safe and Green Development Corporation (NASDAQ: SGD)(“SG DevCo” or the “Company”), is pleased to announce an update on the Norman Berry Village property in Atlanta, GA. David Villarreal, President & CEO of SG DevCo, stated, “It is with great pleasure for me to announce the progression of the Norman Berry project. We have secured financing to acquire the previously announced ROW on the property and an 18,000 square foot adjacent parcel that we believe will collectively significantly increase the value of the Norman Berry parcel.” “I am also very pleased with our partner CMC Development Group, a leading development firm in the area, and the constant communication between our two companies. CMC was crucial in receiving approval from the city of Eastpoint to purchase the project’s...

Invesco Ltd: Form 8.3 – Virgin Money UK PLC_OPD

Written by Customer Service on March 8, 2024. Posted in Mergers And Acquisitions.

FORM 8.3 OPENING POSTION DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)Full name of discloser:Invesco Ltd. (b)Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c)Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offereeVirgin Money UK plc (d)If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e)Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior to the disclosure07.02.2024 (f)In addition...

Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer’s at the AD/PD™ 2024 Annual Meeting

Written by Customer Service on March 8, 2024. Posted in Public Companies.

– Cerebrospinal fluid (CSF) biomarker results are highly supportive of sabirnetug’s downstream pharmacological effects in the brain in early AD – Poster presentation showcases method used to develop a first-of-its-kind assay to assess sabirnetug’s binding to amyloid beta oligomers (AβOs) in Alzheimer’s disease – Company on track to initiate Phase 2 trial evaluating sabirnetug in the first half of 2024 and Phase 1 subcutaneous study in mid-2024 CHARLOTTESVILLE, Va., March 08, 2024 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), today presented cerebrospinal fluid (CSF) biomarker data from the sabirnetug (ACU193) Phase 1 INTERCEPT-AD...

PodcastOne (NASDAQ: PODC) Subsidiary of (NASDAQ: LVO) President and Co-Founder Kit Gray to Present at the 36th Annual ROTH Conference March 17-19, 2024

Written by Customer Service on March 8, 2024. Posted in Public Companies.

LOS ANGELES, CA, March 08, 2024 (GLOBE NEWSWIRE) — via NewMediaWire –PodcastOne (NASDAQ: PODC), a leading podcast platform and a subsidiary of LiveOne (NASDAQ: LVO) announced today that PodcastOne’s President and Co-Founder Kit Gray will present at the 36th Annual ROTH Conference from March 17-19, 2024 in Dana Point, CA. The Annual ROTH Conference, one of the largest in the nation for small-cap companies, combines company presentations, Q&A sessions and management 1-on-1 meetings. The conference provides investors the opportunity to participate in one-on-one and small group meetings, analyst-selected fireside chats, industry keynotes and panels. To submit your ROTH Conference registration request, click here. To schedule a one-on-one meeting, please contact your ROTH representative. About PodcastOnePodcastOne (Nasdaq: PODC)...

Day: March 8, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice